Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

7.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.1K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
Metastasis02:30

Metastasis

5.9K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.9K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

3.4K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.4K
What is Metabolism?00:52

What is Metabolism?

122.9K
Overview
122.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Barriers to pregnancy and parenthood during urology residency across Europe.

BJUI compass·2026
Same author

Biochemical bone biomarkers in plasma cell dyscrasias.

British journal of haematology·2026
Same author

Metabolism in Tumour-Induced Bone Disease.

Current osteoporosis reports·2026
Same author

Cost Effectiveness of Local Anaesthetic Transperineal Versus Transrectal Biopsy: Results from the TRANSLATE Study.

European urology focus·2025
Same author

Local anaesthetic transperineal biopsy versus transrectal prostate biopsy in prostate cancer detection (TRANSLATE): a multicentre, randomised, controlled trial.

The Lancet. Oncology·2025
Same author

ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cells.

Nature cancer·2024

Related Experiment Video

Updated: Oct 26, 2025

Measuring Bone Remodeling and Recreating the Tumor-Bone Microenvironment Using Calvaria Co-culture and Histomorphometry
08:24

Measuring Bone Remodeling and Recreating the Tumor-Bone Microenvironment Using Calvaria Co-culture and Histomorphometry

Published on: March 14, 2020

7.0K

Metabolism in the Tumour-Bone Microenvironment.

Jessica Whitburn1, Claire M Edwards2,3

  • 1Nuffield Dept. of Surgical Sciences, University of Oxford, Oxford, UK.

Current Osteoporosis Reports
|July 28, 2021
PubMed
Summary

Cancer cells in bone adapt their metabolism to grow and survive, driving disease progression. Understanding these metabolic changes in the tumor-bone microenvironment can reveal new therapeutic targets for bone cancers.

Keywords:
BoneCancerGlycolysisMetabolismMetastasisMicroenvironment

More Related Videos

Models of Bone Metastasis
08:49

Models of Bone Metastasis

Published on: September 4, 2012

42.5K
Using Real-Time Cell Metabolic Flux Analyzer to Monitor Osteoblast Bioenergetics
09:43

Using Real-Time Cell Metabolic Flux Analyzer to Monitor Osteoblast Bioenergetics

Published on: March 1, 2022

3.4K

Related Experiment Videos

Last Updated: Oct 26, 2025

Measuring Bone Remodeling and Recreating the Tumor-Bone Microenvironment Using Calvaria Co-culture and Histomorphometry
08:24

Measuring Bone Remodeling and Recreating the Tumor-Bone Microenvironment Using Calvaria Co-culture and Histomorphometry

Published on: March 14, 2020

7.0K
Models of Bone Metastasis
08:49

Models of Bone Metastasis

Published on: September 4, 2012

42.5K
Using Real-Time Cell Metabolic Flux Analyzer to Monitor Osteoblast Bioenergetics
09:43

Using Real-Time Cell Metabolic Flux Analyzer to Monitor Osteoblast Bioenergetics

Published on: March 1, 2022

3.4K

Area of Science:

  • Oncology
  • Metabolic Biology
  • Cancer Research

Background:

  • Bone is a critical microenvironment for solid tumors (e.g., breast, prostate) and hematological malignancies (e.g., myeloma).
  • Cellular crosstalk within the bone microenvironment influences tumor growth, survival, and the development of bone disease.
  • Metabolic reprogramming is increasingly recognized as crucial for cancer cells to adapt to environmental pressures.

Purpose of the Study:

  • To review the current understanding of metabolic requirements and adaptations within the tumor-bone microenvironment.
  • To highlight the role of metabolic reprogramming in driving cancer progression in bone.
  • To identify potential therapeutic targets based on metabolic adaptations.

Main Methods:

  • Review of existing literature on cancer metabolism and the bone microenvironment.
  • Discussion of metabolomics approaches to study metabolic plasticity in cancer patients.
  • Analysis of metabolic crosstalk between tumor cells and bone stroma.

Main Results:

  • Bone offers a unique metabolic niche with energy-intensive processes (resorption, formation) dysregulated by cancer.
  • Metabolomics reveals significant metabolic plasticity in advanced cancer patients.
  • Metabolic reprogramming within the tumor-bone microenvironment is key to disease progression.

Conclusions:

  • Understanding metabolic adaptations in the tumor-bone microenvironment is essential for cancer therapy.
  • Targeting metabolic reprogramming offers promising new therapeutic strategies for bone-associated cancers.
  • Further research into tumor-bone metabolic crosstalk can uncover novel treatment approaches.